VIR Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Sell

24

19 3 5

Oscillators

Neutral

40

5 2 3

Moving averages

Strong Sell

15

14 1 2

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 5, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$1.46B

Growth and income

Eps-3.13

Free Cash Flow$-214.93M

Net Income$-125.7M

Profitability

Ebitda$-451.05M

Gross Profit$63.73M

Balance sheet

Free Cash Flow$-214.93M

Total Assets$1.03B

Total Liabilities$212.82M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

BEAMBEAM THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement DNLIDENALI THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement IOVAIOVANCE BIOTHERAPEUTICS INC+0.00%Market co-movement · Residual co-movement RCUSARCUS BIOSCIENCES INC+0.00%Market co-movement · Residual co-movement PCVXVAXCYTE INC+0.00%Market co-movement · Residual co-movement

RelationshipsLoading

VIR BIOTECHNOLOGY INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships